HL7 FHIR Implementation Guide - New Zealand Formulary/NZULM IG
1.0.0 - ci-build
HL7 FHIR Implementation Guide - New Zealand Formulary/NZULM IG, published by New Zealand Medicines Formulary LP. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7NZ/nzf/ and changes regularly. See the Directory of published versions
The standard Medication resource provides the key information needed for integration however we have defined several extensions to allow for the addition of specific NZULM/Formulary information. The following table describes these extensions and shows which extensions apply to which medication type.
| Extension | Description | MP | TP | MPUU | TPUU | MPP | TPP | CTPP |
|---|---|---|---|---|---|---|---|---|
| Type | Type of NZMT reference (e.g. CTPP, MPUU) etc. | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Descriptions | Specific NZMT descriptions that apply to this medication | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Cautionary and Advisory Labels (CALs) | List of all Cautionary and Advisory labels associated with the medication | Yes | Yes | Yes | Yes | Yes | ||
| ATC | The Anatomical Therapeutic Chemical Classification code(s) | Yes | Yes | Yes | Yes | Yes | Yes | |
| Unapproved | True if the medication has not been approved by Medsafe and can be prescribed under section 29 | Yes | ||||||
| Legal Classification | Medsafe legal classification | Yes | Yes | Yes | ||||
| Medsafe | Medsafe status, regSituation and routes of administation | Yes | ||||||
| Prescribe by Brand | Whether the medication should be prescribed by brand or not | Yes | Yes | |||||
| Funding | NZ specific funding information provided by PHARMAC | Yes | ||||||
| Funding rules | The rules and constraints around funding for the given medicine provided by PHARMAC | Yes | ||||||
| PHARMAC Supply Information | PHARMAC provided information detailing medication supply issues | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Links | Links to associated resources, such as monographs, datasheets and patient information leaflets | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| NZF Pack details | Unit quantity and (if applicable) unit size details for the given medicine pack | Yes | ||||||
| Related medication | A related medication within the NZMT hierarchy | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| NZF Medication Sponsor | Organization sponsoring the medication | Yes |
| Id | Url | Context of Use | Description | Purpose | FMM | Status |
|---|---|---|---|---|---|---|
| nzf-atc | http://hl7.org.nz/fhir/StructureDefinition/nzf-atc |
Medication
|
Anatomical Therapeutic Chemical (ATC) Classification - see https://www.who.int/tools/atc-ddd-toolkit/atc-classification | 0 | draft | |
| nzf-cal | http://hl7.org.nz/fhir/StructureDefinition/nzf-cal |
Medication
|
Cautionary and Advisory Label | 0 | draft | |
| nzf-description | http://hl7.org.nz/fhir/StructureDefinition/nzf-description |
Medication
|
Specific NZMT descriptions that apply to this medication | 0 | draft | |
| nzf-funding-rule | http://hl7.org.nz/fhir/StructureDefinition/nzf-funding-rule |
Medication
|
Funding restriction information which complements the general funding information provided in the nzf-funding extension. The extension can be added multiple times to a product for each given rule as well as for each PHARMAC schedule. These can be differentiated via the scheduleDate field. | 0 | draft | |
| nzf-funding | http://hl7.org.nz/fhir/StructureDefinition/nzf-funding |
Medication
|
Core funding information specific to NZ. The extension can be added multiple times to a product for each PHARMAC schedule. These can be differentiated via the scheduleDate field. | 0 | draft | |
| nzf-is-primary-coding | http://hl7.org.nz/fhir/StructureDefinition/nzf-is-primary-coding |
Coding
|
Is primary code within given context, e.g. primary Pharmacode® when multiple given | 0 | draft | |
| nzf-legalclass | http://hl7.org.nz/fhir/StructureDefinition/nzf-legalclass |
Medication
|
Legal classification | 0 | draft | |
| nzf-link | http://hl7.org.nz/fhir/StructureDefinition/nzf-link |
Medication
|
Reference to other information about this medication | 0 | draft | |
| nzf-medication-sponsor | http://hl7.org.nz/fhir/StructureDefinition/nzf-medication-sponsor |
Medication
|
Organization sponsoring this medication | 0 | draft | |
| nzf-medsafe | http://hl7.org.nz/fhir/StructureDefinition/nzf-medsafe |
Medication
|
Medsafe package, reg situation and administration route details | 0 | draft | |
| nzf-nzmtType | http://hl7.org.nz/fhir/StructureDefinition/nzf-nzmt-type |
Medication
|
The NZ Medicines Terminology (NZMT) Data Class – MP (Medicinal Product), MPUU (Medicinal Product Unit of Use), MPP (Medicinal Product Pack), TP (Trade Product), TPUU (Trade Product Unit of Use), TPP (Trade Product Pack) or CTPP (Containered Trade Product Pack) – that the Medication is a member of. | 0 | draft | |
| nzf-pack | http://hl7.org.nz/fhir/StructureDefinition/nzf-pack |
Medication
|
NZF Pack detail | 0 | draft | |
| nzf-page-size | http://hl7.org.nz/fhir/StructureDefinition/nzf-page-size |
DocumentReference.content.attachment
|
Attachment page size | 0 | draft | |
| nzf-pil-dose-form | http://hl7.org.nz/fhir/StructureDefinition/nzf-pil-dose-form |
DocumentReference.context
|
Doseform that this PIL applies to | 0 | draft | |
| nzf-pil-formulary | http://hl7.org.nz/fhir/StructureDefinition/nzf-pil-formulary |
DocumentReference.context
|
Applicable formulary for PIL | 0 | draft | |
| nzf-pil-indication | http://hl7.org.nz/fhir/StructureDefinition/nzf-pil-indication |
DocumentReference.context
|
Indication that this PIL applies to | 0 | draft | |
| nzf-pil-route-of-admin | http://hl7.org.nz/fhir/StructureDefinition/nzf-pil-route-of-admin |
DocumentReference.context
|
Route of admin that this PIL applies to | 0 | draft | |
| nzf-pil-source | http://hl7.org.nz/fhir/StructureDefinition/nzf-pil-source |
DocumentReference.context
|
Source of the PIL (e.g. mymedicines) | 0 | draft | |
| nzf-prescribe-by-brand | http://hl7.org.nz/fhir/StructureDefinition/nzf-prescribe-by-brand |
Medication
|
True if can be prescribed by brand | 0 | draft | |
| nzf-related-medication | http://hl7.org.nz/fhir/StructureDefinition/nzf-related-medication |
Medication
|
A related medication within the NZMT hierarchy | 0 | draft | |
| nzf-supply-information | http://hl7.org.nz/fhir/StructureDefinition/nzf-supply-information |
Medication
|
Information around the supply and availability of medications applied at each NZMT level. For example, when paracetamol tablets are in short supply an alert may be attached to the MP level medication along with the relevant details. | 0 | draft | |
| nzf-unapproved | http://hl7.org.nz/fhir/StructureDefinition/nzf-unapproved |
Medication
|
True if this medication has not been approved by Medsafe and can be prescribed under section 29 | 0 | draft | |
| stockleys-interaction-evidence-code | http://hl7.org.nz/fhir/StructureDefinition/stockleys-interaction-evidence-code |
ClinicalUseDefinition
|
undefined | 0 | draft | |
| stockleys-interaction-modification-date | http://hl7.org.nz/fhir/StructureDefinition/stockleys-interaction-modification-date |
ClinicalUseDefinition
|
undefined | 0 | draft | |
| stockleys-interaction-review-date | http://hl7.org.nz/fhir/StructureDefinition/stockleys-interaction-review-date |
ClinicalUseDefinition
|
undefined | 0 | draft | |
| stockleys-interaction-route | http://hl7.org.nz/fhir/StructureDefinition/stockleys-interaction-route |
ClinicalUseDefinition
|
undefined | 0 | draft | |
| stockleys-interaction-severity-code | http://hl7.org.nz/fhir/StructureDefinition/stockleys-interaction-severity-code |
ClinicalUseDefinition
|
undefined | 0 | draft | |
| stockleys-interaction-text-link | http://hl7.org.nz/fhir/StructureDefinition/stockleys-interaction-text-link |
ClinicalUseDefinition
|
undefined | 0 | draft | |
| stockleys-interaction-warning-code | http://hl7.org.nz/fhir/StructureDefinition/stockleys-interaction-warning-code |
ClinicalUseDefinition
|
undefined | 0 | draft |
| Path | Url | Description | IG where defined |
|---|